There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...

Phase II study to evaluate the potential of HB-adMSCs in reducing inflammation and improving quality of life for adults living with Crohn’s Disease Hope Biosciences Research Foundation (HBRF) today ...

Among adults with difficult to treat Crohn disease not amenable to surgery, hematopoietic stem cell transplantation, compared with conventional therapy, did not result in significant improvement in ...

Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...

The use of stem cell transplantation, particularly autologous haematopoietic stem cell transplantation (AHSCT), has emerged as a promising treatment modality in autoimmune diseases. This approach ...

Stem cells can fight disease from the inside out. But not all treatments are created equal. By Mohana Ravindranath The promise of stem cell therapy is powerful. Scientists can draw versatile cells ...

PHILADELPHIA, Oct. 21, 2025 /PRNewswire/ -- In a new study led by researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania (Penn ...

While currently small molecules and biologics are ruling the Crohn's disease treatment space, in 2018, a cell therapy was also introduced in the market. ALOFISEL (darvadstrocel), an allogeneic stem ...